Journey Medical Corporation DERM
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -32.94%
- 1 year
- -37.79%
- Open
- 5.36
- Prev close
- 5.41
- Mkt cap
- 145.92M
- Vol
- 235.06K
- Avg vol
- 197.05K
- EPS
- -0.22
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.10
- High
- 5.36
- Forward P/E
- -75.83
- Beta
- 0.00
- Short ratio
- 0.55
- Inst. own
- 24.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 5.50
- 200-d avg
- 4.83
- 1y target
- 10.00
5D chart
Signals (66)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:15 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:15 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:00 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:30 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 12:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:25 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:35 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:20 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:25 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:20 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 3:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:50 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:05 AM | 6 days ago |
| SMA: Bearish | Oct 23, 3:40 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:40 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:15 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:00 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:45 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:40 PM | 1 week ago |
News
-
6 days ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Journey Medical (NASDAQ:DERM) with a Buy and maintains $13 price target.
3 weeks ago defenseworld.net
Vireo Growth (OTCMKTS:VREOD) vs. Journey Medical (NASDAQ:DERM) Critical Contrast
Journey Medical (NASDAQ: DERM - Get Free Report) and Vireo Growth (OTCMKTS:VREOD - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the…
1 month ago seekingalpha.com
Journey Medical: A Small Pharma With A Large Growth Opportunity
Journey Medical (DERM) is rated Buy, driven by Emrosi's rapid prescription growth and expanding payer coverage. DERM leverages existing infrastructure for Emrosi, achieving high gross margins and…
1 month ago globenewswire.com
Journey Medical Corporation to Participate in September 2026 Investor Conferences
SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on developing, selling and…
2 months ago zacks.com
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?
Elite Pharmaceuticals and Journey Medical follow different growth paths, but which looks more compelling now? Let's dive in.
2 months ago seekingalpha.com
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction
Journey Medical demonstrates strong Emrosi prescription growth, rebounding from Q1 lows with Q2 revenues up 23% to $18.5M and positive EBITDA. DERM's Emrosi franchise is gaining traction, with…
-
2 months ago benzinga.com
B. Riley Securities Reiterates Buy on Journey Medical, Raises Price Target to $15
B. Riley Securities analyst Mayank Mamtani reiterates Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $12 to $15.
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.9% to $0.17 during Thursday's pre-market session. The company's market cap stands at $7.2 million. LENSAR (NASDAQ:LNSR) shares…
2 months ago seekingalpha.com
Journey Medical Corporation (DERM) Q2 2026 Earnings Call Transcript
Journey Medical Corporation (DERM) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings
The headline numbers for Journey Medical (DERM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
-
2 months ago benzinga.com
Journey Medical Q2 EPS $(0.01) Beats $(0.02) Estimate, Sales $17.839M Miss $18.366M Estimate
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 93.75 percent increase over losses of…
2 months ago globenewswire.com
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on…
5 months ago globenewswire.com
Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on…
5 months ago seekingalpha.com
Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript
Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript
5 months ago zacks.com
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
Journey Medical Corporation (DERM) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.18 per share a year ago.
5 months ago benzinga.com
Transcript: Journey Medical Q1 2026 Earnings Conference Call
Transcript: Journey Medical Q1 2026 Earnings Conference Call
-
5 months ago benzinga.com
Journey Medical Q1 EPS $(0.08), Inline, Sales $15.961M Beat $15.948M Estimate
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 55.56 percent increase over losses of $(0.18) per share from the same…
5 months ago globenewswire.com
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position…
5 months ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are…
5 months ago globenewswire.com
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
Company to host conference call to discuss financial results and provide a corporate update on May 13, 2026 at 4:30 p.m. ET Company to host conference call to discuss financial results and provide a…
5 months ago zacks.com
Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know
Journey Medical (DERM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 months ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are…
6 months ago globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation (“Journey” or the “Company”) (NASDAQ: DERM). Such investors…
6 months ago globenewswire.com
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
Payer access for Emrosi™ expanded from approximately 100 million commercial lives to over 150 million commercial lives as of April 1, 2026 Payer access for Emrosi™ expanded from approximately 100…
6 months ago prnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Journey Medical Corporation ("Journey" or the "Company") (NASDAQ: DERM). Such investors are…
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
7 months ago benzinga.com
HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Journey Medical (NASDAQ:DERM) with a Buy and maintains $13 price target.
-
7 months ago benzinga.com
Journey Medical Q4 EPS $(0.04) Beats $(0.06) Estimate, Sales $16.079M Miss $18.863M Estimate
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 31.03 percent. This is a 150 percent decrease over earnings of…
-
7 months ago benzinga.com
Earnings Scheduled For March 25, 2026
Earnings Scheduled For March 25, 2026
-
9 months ago benzinga.com
Journey Medical Files $3.75M At-The-Market Common Stock Offering With B. Riley And Lake Street
3,750,000 SHARES OF COMMON STOCKWe have entered into an At Market Issuance Sales Agreement (the "Sales Agreement") with B. Riley Securities, Inc. ("B. Riley") and Lake Street Capital Markets, LLC…
11 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
11 months ago benzinga.com
Journey Medical Q3 EPS $(0.09) Misses $(0.04) Estimate, Sales $17.631M Miss $18.854M Estimate
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 143.24 percent. This is a 25 percent increase over losses of…
-
11 months ago benzinga.com
Earnings Scheduled For November 12, 2025
Earnings Scheduled For November 12, 2025
11 months ago benzinga.com
Insights into Journey Medical's Upcoming Earnings
Insights into Journey Medical's Upcoming Earnings
-
1 year ago benzinga.com
Journey Medical Corporation Releases Pooled Phase 3 Data From Its MVOR-1 And MVOR-2 Trials Evaluating DFD-29 Demonstrating Emrosi's Statistical Superiority Over Oracea And Placebo In Achieving Investigator's Global Assessment Treatment Success And Reducing Inflammatory Lesion Counts
FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory…
-
1 year ago benzinga.com
HC Wainwright & Co. Initiates Coverage On Journey Medical with Buy Rating, Announces Price Target of $13
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Journey Medical (NASDAQ:DERM) with a Buy rating and announces Price Target of $13.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
Lake Street Maintains Buy on Journey Medical, Raises Price Target to $13
Lake Street analyst Thomas Flaten maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $9 to $13.
1 year ago benzinga.com
CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
1 year ago benzinga.com
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday that it will be acquired by global private equity firm Advent in an…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
1 year ago benzinga.com
Journey Medical Q2 EPS $(0.16) Misses $(0.10) Estimate, Sales $15.009M Beat $14.933M Estimate
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.10) by 60 percent. This is a 5.88 percent increase over losses of…
-
1 year ago benzinga.com
Earnings Scheduled For August 12, 2025
Earnings Scheduled For August 12, 2025
-
1 year ago benzinga.com
Examining the Future: Journey Medical's Earnings Outlook
Examining the Future: Journey Medical's Earnings Outlook
-
1 year ago benzinga.com
B. Riley Securities Maintains Buy on Journey Medical, Raises Price Target to $12
B. Riley Securities analyst Kalpit Patel maintains Journey Medical (NASDAQ:DERM) with a Buy and raises the price target from $9 to $12.
-
1 year ago benzinga.com
Journey Medical's Emrosi Now Covered For 65% Of U.S. Commercial Lives, Up From 29% In May
Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to…
-
1 year ago benzinga.com
Journey Medical To Join Russell 2000 And Russell 3000 Indexes, Effective After The Close Of U.S. Equity Markets On June 27, 2025
Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical" or the "Company", "we", or "our"), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session